Pathstone Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Sell |
30,041
-1,356
| -4% | -$1.28K | ﹤0.01% | 2148 |
|
|
2025
Q1 | $14.5K | Sell |
31,397
-22,654
| -42% | -$10.4K | ﹤0.01% | 2194 |
|
|
2024
Q4 | $39.9K | Sell |
54,051
-4,908
| -8% | -$3.62K | ﹤0.01% | 2272 |
|
|
2024
Q3 | $92.6K | Sell |
58,959
-1,079
| -2% | -$1.69K | ﹤0.01% | 2236 |
|
|
2024
Q2 | $101K | Sell |
60,038
-2,687
| -4% | -$4.51K | ﹤0.01% | 2218 |
|
|
2024
Q1 | $151K | Buy |
62,725
+28,280
| +82% | +$67.9K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $52.7K | Buy |
+34,445
| New | +$52.7K | ﹤0.01% | 2164 |
|